Testing effectiveness (Phase 2)Ended earlyNCT04189445
What this trial is testing
Futibatinib in Patients With Specific FGFR Aberrations
Who this might be right for
Advanced or Metastatic Solid TumorAdvanced or Metastatic Gastric or Gastroesophageal CancerMyeloid or Lymphoid Neoplasms (MLN)
Taiho Oncology, Inc. 115